References
- 1. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 1993;261(5124):1041-4. DOI: 10.1126/science.8351518
- 2. Kundu M, Liu PP. Function of the inv(16) fusion gene CBFB-MYH11. Curr Opin Hematol. 2001;8(4):201-5. DOI: 10.1097/00062752-200107000-00004
- 3. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004;103(11):4010-22. DOI: 10.1182/ blood-2003-12-4111
- 4. Colovic M, Jankovic G, Bila J, Djordjevic V, Wiernik PH. Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature. Med Oncol. 1998;15(3):199-201. DOI: 10.1007/BF02821939
- 5. Enright H, Weisdorf D, Peterson L, Rydell RE, Kaplan ME, Arthur DC. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Leukemia. 1992;6(5):381-4.
- 6. Myint H, Ross FM, Hall JL, Hamblin TJ. Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia. Leuk Res. 1997;21(5):473-4. DOI: 10.1016/ S0145-2126(97)00070-2
- 7. Heim S, Christensen BE, Fioretos T, Sorensen AG, Pedersen NT. Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;59(1):35-8. DOI: 10.1016/0165-4608(92)90154-Z
- 8. Miura I, Takatsu H, Yamaguchi A, Hashimoto K, Nimura T, Nishinari T, et al. Standard Ph chromosome, t(9;22)(q34;q11), as an additional change in a patient with acute myelomonocytic leukemia (M4Eo) associated with inv(16)(p13q22). Am J Hematol. 1994;45(1):94-6. DOI: 10.1002/ajh.2830450118
- 9. Patel BB, Mohamed AN, Schiffer CA. „Acute myelogenous leukemia like” translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature. Leuk Res. 2006;30(2):225-32. DOI: 10.1016/j.leukres.2005.06.008
- 10. Wu Y, Slovak ML, Snyder DS, Arber DA. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias : report of six cases and review of literature. Am J Clin Pathol. 2006;125(2):260-6. DOI: 10.1309/F0MX-5CL8- CEDY-3W86 DOI: 10.1309/F0MX5CL8CEDY3W86
- 11. Tirado CA, Valdez F, Klesse L, Karandikar NJ, Uddin N, Arbini A, et al. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3’CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genet Cytogenet. 2010;200(1):54-9. DOI: 10.1016/j.cancergencyto. 2010.03.001
- 12. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of ‚real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia. 2003;17(12):2318-57. DOI: 10.1038/sj.leu.2403135
- 13. Gribble SM, Reid AG, Roberts I, Grace C, Green AR, Nacheva EP. Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation. Genes Chromosomes Cancer. 2003;37(4):346-58. DOI: 10.1002/gcc.10173
- 14. Han E, Lee H, Kim M, Kim Y, Han K, Lee SE, et al. Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities. Blood Res. 2014;49(1):22-8. DOI: 10.5045/ br.2014.49.1.22
- 15. Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D, et al. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005;124(5):807-14. DOI: 10.1309/3HFE16DKMB1DBFMN
- 16. Dai HP, Xue YQ, Wu LL, Pan JL, Gong YL, Wu YF, et al. p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16). Int J Hematol. 2012;96(6):814-7. DOI: 10.1007/s12185-012-1190-y
- 17. Bustamante D, Chan KR, Czuchlewski DR, Saadi AA. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2). Int J Hematol. 2012;95(3):324-6. DOI: 10.1007/s12185-011-0990-9
- 18. Ninomiya S, Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, et al. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Int J Hematol. 2011;93(6):806-10. DOI: 10.1007/s12185-011-0854-3
- 19. Grardel N, Roumier C, Soenen V, Lai JL, Plantier I, Gheveart C, et al. Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta- MYH11 transcript: report of two new cases. Leukemia. 2002;16(1):150-1. DOI: 10.1038/sj.leu.2402332
- 20. Roth CG, Contis L, Gupta S, Agha M, Safyan E. De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB- MYH11): report of two cases and review of the literature. Leuk Lymphoma. 2011;52(3):531-5. DOI: 10.3109/10428194.2010.538941
- 21. Soverini S, Hochhaus A, Nicolini FE, Gruber F, Lange T, Saglio G, et al. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. Blood. 2011;118(5):1208-15. DOI: 10.1182/ blood-2010-12-326405